BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35373693)

  • 1. Evaluation of needling/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study.
    Esmat S; Assaf MI; Mohye Eldeen R; Gawdat HI; Saadi DG
    J Dermatolog Treat; 2022 Aug; 33(5):2621-2628. PubMed ID: 35373693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
    Kaur A; Barman KD; Sahoo B; Choudhary P
    Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo.
    Neinaa YME; Lotfy SS; Ghaly NR; Doghaim NN
    Dermatol Ther; 2021 Mar; 34(2):e14813. PubMed ID: 33497514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.
    Fawzy M; Al-Mokadem S; Alshereef M; Elkholy B
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12929. PubMed ID: 37984828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
    Thind A; Vinay K; Mehta H; Bishnoi A; Kumaran MS; Parsad D
    Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of NB-UVB combination therapy regimens for vitiligo: A systematic review and network meta-analysis.
    Zhu B; Liu C; Zhang L; Wang J; Chen M; Wei Y
    J Cosmet Dermatol; 2023 Mar; 22(3):1083-1098. PubMed ID: 36456176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
    Anbar TS; Mohammed SS; Mohamed DM; Abdel-Rahman AT
    Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered levels of lymphocyte enhancer-binding factor-1 modulates the pigmentation in acral and non-acral lesions of non-segmental vitiligo patients: a follow-up-based study in North India.
    Nayak D; Srivastava N; Dev A; Bishnoi A; Kumaran MS; Vinay K; Parsad D
    Arch Dermatol Res; 2023 Sep; 315(7):2003-2009. PubMed ID: 36877308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
    Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
    J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
    Shin J; Lee JS; Hann SK; Oh SH
    Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo.
    El-Zawahry BM; Bassiouny DA; Sobhi RM; Abdel-Aziz E; Zaki NS; Habib DF; Shahin DM
    Photodermatol Photoimmunol Photomed; 2012 Apr; 28(2):84-90. PubMed ID: 22409711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of fractional carbon dioxide laser combined with narrow-band ultraviolet B phototherapy for non-segmental vitiligo: a systematic review and meta-analysis.
    Kim WI; Kim S; Lee SH; Cho MK
    Lasers Med Sci; 2021 Feb; 36(1):165-173. PubMed ID: 32572662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
    Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
    Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
    J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of Janus kinase inhibitors and narrowband ultraviolet B combination therapy in non-segmental vitiligo.
    Yousefian F; Yadlapati S; Browning JC
    J Cosmet Dermatol; 2023 Mar; 22(3):1105-1107. PubMed ID: 36440703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
    Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
    Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No Additional Benefit of Combining Fractional Carbon Dioxide Laser With Narrow-Band Ultraviolet B Phototherapy for Vitiligo: A Randomized Prospective Study With Half-Body Side Comparison.
    Eşme P; Gür Aksoy G; Elçin G
    Dermatol Surg; 2019 Dec; 45(12):1627-1634. PubMed ID: 30829772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.